StonvexLoading…
StonvexStonvexStonvexCore line items from FUL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-11-29 | Annual 2024 2024-11-30 | Annual 2023 2023-12-02 | Annual 2022 2022-12-03 |
|---|---|---|---|---|
Revenue | $3.47B | $3.57B | $3.51B | $3.75B |
Operating Income | $215.42M | $348.22M | $355.14M | $322.72M |
Net Income | $151.97M | $130.26M | $144.91M | $180.31M |
EPS (Diluted) | $2.75 | $2.30 | $2.59 | $3.26 |
Total Assets | $5.18B | $4.93B | $4.72B | $4.46B |
Total Liabilities | $3.18B | $3.10B | $2.97B | $2.85B |
Cash & Equivalents | $107.21M | $169.35M | $179.45M | $79.91M |
Free Cash Flow OCF − CapEx | $121.22M | $163.20M | $259.26M | $126.55M |
Shares Outstanding | 54.17M | 54.66M | 54.09M | 53.68M |